Quadrant Private Wealth Management’s Zimmer Biomet ZBH Stock Holding History

Quadrant Private Wealth Management’s Portfolio ZBH Stock Details ZBH Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-1,567	Closed	-$229K	–	253
2023 Q2	$229K	Buy	+1,567	New	+$213K	0.07%	220
2022 Q2	–	Sell	-1,802	Closed	-$231K	–	224
2022 Q1	$231K	Buy	+1,802	New	+$217K	0.09%	187

Other funds holding ZBH

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Quadrant Private Wealth Management's ZBH Position: Q3 2023 in Review

Quadrant Private Wealth Management sold out of Zimmer Biomet (ZBH) in Q3 2023, closing a stake of 1,567 shares — an estimated $229K sold.

Quadrant Private Wealth Management first reported a position in ZBH in Q1 2022 and held it in 2 quarters. The position peaked at $231K in Q1 2022. 1,016 funds tracked by Wall St. Rank hold ZBH as of Q3 2023.

Quadrant Private Wealth Management reported no remaining Zimmer Biomet position as of Q3 2023 after selling out during the quarter.
Quadrant Private Wealth Management sold 1,567 Zimmer Biomet shares in Q3 2023, an estimated $229K.
Quadrant Private Wealth Management first reported a position in Zimmer Biomet in Q1 2022 and held it in 2 quarters.
Quadrant Private Wealth Management's Zimmer Biomet position peaked at $231K in Q1 2022.
1,016 funds tracked by Wall St. Rank held Zimmer Biomet as of Q3 2023.

Based on Quadrant Private Wealth Management's 13F filing for Q3 2023, filed 13 Nov 2023.